Profil

Maquoi Erik

GIGA Cancer - Tumours and development biology

Département des sciences biomédicales et précliniques

Département des sciences cliniques > Labo de biologie des tumeurs et du développement

See author's contact details
ORCID
0000-0002-2193-0800
Main Referenced Co-authors
Noël, Agnès  (51)
Foidart, Jean-Michel  (33)
Blacher, Silvia  (13)
Sounni, Nor Eddine  (13)
Colige, Alain  (12)
Main Referenced Keywords
obesity (9); cancer (6); adipose tissue (5); Breast cancer (4); adipocyte (3);
Main Referenced Unit & Research Centers
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège (6)
Laboratoire de Biologie des Tumeurs et du Développement - LBTD (2)
CERM - Center for Education and Research on Macromolecules - ULiège (1)
CESAM - Complex and Entangled Systems from Atoms to Materials - ULiège (1)
GIGA - Cancer - ULiège (1)
Main Referenced Disciplines
Oncology (31)
Biochemistry, biophysics & molecular biology (22)
Pharmacy, pharmacology & toxicology (11)
Endocrinology, metabolism & nutrition (10)
Anatomy (cytology, histology, embryology...) & physiology (9)

Publications (total 84)

The most downloaded
633 downloads
Maquoi, E., Demeulemeester, D., Vörös, G., Collen, D., & Lijnen, R. (April 2003). Enhanced nutritionally induced adipose tissue development in mice with stromelysin-1 gene inactivation. Thrombosis and Haemostasis, 89 (4), 696-704. doi:10.1055/s-0037-1613586 https://hdl.handle.net/2268/102261

The most cited

261 citations (OpenAlex)

Maquoi, E., Munaut, C., Colige, A., Collen, D., & Lijnen, R. (April 2002). Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes, 51 (4), 1093-1101. doi:10.2337/diabetes.51.4.1093 https://hdl.handle.net/2268/14933

Berger, M., Toussaint, F., Ben Djemaa, S., Maquoi, E., Pendeville-Samain, H., Evrard, B., Jérôme, C., Leblond Chain, J., Lechanteur, A., Mottet, D., Debuigne, A., & Piel, G. (March 2024). Innovative siRNA-based lipid nanoparticles decorated with PEG alternatives (PNVP and PNMVA) to circumvent dilemma and immunogenicity [Paper presentation]. 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical (PBP) Technology, Vienne, Austria.
Peer reviewed

Bériot, D., Maquoi, E., Noël, A., & Colige, A. (2024). Catelysine, a potential regulator of tumor stroma to fight breast cancer? [Poster presentation]. CIRM Day 2024, Liège, Belgium.
Editorial reviewed

Berger, M.* , Toussaint, F.* , Djemaa, S. B.* , Maquoi, E., Pendeville-Samain, H., Evrard, B., Jérôme, C., Chain, J. L., Lechanteur, A., Mottet, D.* , Debuigne, A.* , & Piel, G.*. (2023). Poly(N-methyl‐N‐vinylacetamide): a strong alternative to PEG for lipid‐based nanocarriers delivering siRNA. Advanced Healthcare Materials, 2302712. doi:10.1002/adhm.202302712
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (27 April 2023). Effect of PEG anchor and serum on Lipid Nanoparticles: development of a nanoparticle tracking method [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (21 March 2023). Impact of the hydrophobic chain length of PEG derivatives on the behavior of LNPs in serum: Development of a Nanoparticle Tracking Analysis (NTA) Method [Poster presentation]. 4th European Conference on Pharmaceutics, Marseille, France.
Peer reviewed

Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (10 February 2023). Effect of PEG Anchor and Serum on Lipid Nanoparticles: Development of a Nanoparticles Tracking Method. Pharmaceutics, 15 (2). doi:10.3390/pharmaceutics15020597
Peer Reviewed verified by ORBi

Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (01 February 2023). Effect of PEG anchor and serum on Lipid Nanoparticles: development of a nanoparticles tracking method [Paper presentation]. CIRM Day, Liege, Belgium.

Ledoux, A., Hamann, C., Bonnet, O., Jullien, K., Quetin-Leclercq, J., Tchinda, A., Smadja, J., Gauvin-Bialecki, A., Maquoi, E., & Frederich, M. (25 January 2023). Bioactive Clerodane Diterpenoids from the Leaves of Casearia coriacea Vent. Molecules, 28 (3), 1197. doi:10.3390/molecules28031197
Peer Reviewed verified by ORBi

Bériot, D., Maquoi, E., Noël, A., & Colige, A. (2023). Catelysine, a potential regulator of tumor stroma to fight breast cancer? [Poster presentation]. Tumor Heterogeneity, Plasticity and Therapy (2nd edition), Leuven, Belgium.
Editorial reviewed

Bériot, D., Maquoi, E., Noël, A., & Colige, A. (2023). Catelysine, a molecule capable of regulating the tumor stroma and offering new therapeutic options to fight breast cancer? [Poster presentation]. 2023 Télévie Seminar, Woluwe-Saint-Lambert, Belgium.
Editorial reviewed

Bériot, D., Maquoi, E., Noël, A., & Colige, A. (2023). Catelysine, a molecule capable of regulating the tumor stroma and offering new therapeutic options to fight breast cancer? [Paper presentation]. CIRM Day 2023, Liège, Belgium.
Editorial reviewed

Gommes, C., Louis, T., Bourgot, I., Blacher, S., Noël, A., & Maquoi, E. (2023). Remodelling of the fibre-aggregate structure of collagen gels by cancer-associated fibroblasts: a time-resolved grey-tone image analysis based on stochastic modelling. Frontiers in Immunology, 13. doi:10.3389/fimmu.2022.988502
Peer Reviewed verified by ORBi

Hamann, C., Jansen, O., Desdemoustier, P., Ledoux, A., Maquoi, E., & Frederich, M. (28 August 2022). Characterization of the type of interaction between terpenoids and cannabinoids compounds of hemp plant against MDA-MB-231 cancer-cells by isobologram analyses [Poster presentation]. 70th International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research (GA), Thessalonique, Greece.
Peer reviewed

PAYE, A., Truong, A., Yip, C., Cimino, J., Blacher, S., Munaut, C., Cataldo, D., Foidart, J. M., Maquoi, E., Collignon, J., Delvenne, P., Jerusalem, G., Noël, A., & Sounni, N. E. (15 February 2022). Editor's Note: EGFR Activation and Signaling in Cancer Cells Are Enhanced by the Membrane-Bound Metalloprotease MT4-MMP. Cancer Research, 82 (4), 734. doi:10.1158/0008-5472.CAN-21-4292
Peer Reviewed verified by ORBi

Hamann, C., Jansen, O., Desdemoustier, P., Marotte, A., Bonnet, O., Maquoi, E., & Frederich, M. (02 February 2022). Preliminary study of the phytochemical composition and biological activity of 5 varieties of hemp cultivated in Wallonia [Poster presentation]. CIRMDay2022.

Bériot, D., Maquoi, E., Noël, A., & Colige, A. (2022). Catelysine, a molecule capable of regulating the tumor stroma and offering new therapeutic options to fight breast cancer? [Poster presentation]. Interuniversity PhD Student Day, Namur, Belgium.
Editorial reviewed

Bériot, D., Maquoi, E., Noël, A., & Colige, A. (2022). Catelysine, a molecule capable of regulating the tumor stroma and offering new therapeutic options to fight breast cancer? [Poster presentation]. 2022 Télévie Seminar, Liège, Belgium.
Editorial reviewed

Bériot, D., Maquoi, E., Noël, A., & Colige, A. (2022). Catelysine, a molecule capable of regulating the tumor stroma and offering new therapeutic options to fight breast cancer? [Poster presentation]. Matrix Biology Europe 2022, Florence, Italy.
Editorial reviewed

Bériot, D., Maquoi, E., Noël, A., & Colige, A. (2022). Catelysine, a molecule capable of regulating the tumor stroma and offering new therapeutic options to fight breast cancer? [Poster presentation]. GIGA-Day 2022, Liège, Belgium.
Editorial reviewed

Saby, C., Maquoi, E., Saltel, F., & Morjani, H. (22 December 2021). Collagen and Discoidin Domain Receptor 1 Partnership: A Multifaceted Role in the Regulation of Breast Carcinoma Cell Phenotype. Frontiers in Cell and Developmental Biology, 9. doi:10.3389/fcell.2021.808625
Peer Reviewed verified by ORBi

Ledoux, A., Bériot, D., Coelho Cristino Mamede, L. C., Desdemoustier, P., Detroz, F., Jansen, O., Frederich, M., & Maquoi, E. (2021). Cytotoxicity of Poupartone B, an Alkyl Cyclohexenone Derivative from Poupartia borbonica, against Human Cancer Cell Lines. Planta Medica. doi:10.1055/a-1532-2384
Peer Reviewed verified by ORBi

Gallez, A., Blacher, S., Maquoi, E., Konradowski, E., Joiret, M., Primac, I., Gérard, C., Taziaux, M., Houtman, R., Geris, L., Lenfant, F., Marangoni, E., Sounni, N. E., Foidart, J.-M., Noël, A., & Pequeux, C. (2021). Estetrol combined to progestogen for menopause or contraception indication is neutral on breast cancer. Cancers. doi:10.3390/cancers13102486
Peer Reviewed verified by ORBi

Bériot, D., Maquoi, E., Noël, A., & Colige, A. (2021). Catelysine, a molecule capable of regulating the tumor stroma and offering new therapeutic options to fight breast cancer? [Paper presentation]. GIGA-CANCER DAY 2021 "Tumor cell invasion in a complex and heterogenous tumor microenvironnement", Liège, Belgium.
Editorial reviewed

Luis, G.* , Godfroid, A.* , Nishiumi, S., Cimino, J., Blacher, S., Maquoi, E., Wery, C., Collignon, A., Longuespée, R., MONTERORUIZ, L., Dassoul, I., Maloujahmoum, N., Pottier, C., Mazzucchelli, G., De Pauw, E., Bellahcene, A., Yoshida, M., Noël, A., & Sounni, N. E. (2021). Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence. Redox Biology, 43, 102006. doi:10.1016/j.redox.2021.102006
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Bourgot, I.* , Primac, I.* , Louis, T., Noël, A., & Maquoi, E. (18 August 2020). Reciprocal Interplay Between Fibrillar Collagens and Collagen-Binding Integrins: Implications in Cancer Progression and Metastasis. Frontiers in Oncology, 10 (1488). doi:10.3389/fonc.2020.01488
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Saby, C., Collin, G., Sinane, M., Buache, E., VAN GULICK, L., Saltel, F., Maquoi, E., & Morjani, H. (June 2020). DDR1 and MT1-MMP expression are determinant for triggering BIK-mediated apoptosis by 3D type I collagen matrix in invasive basal-like breast carcinoma cells [Poster presentation]. AACR Meeting, United States.

Azarkan, M., Maquoi, E., Delbrassine, F., Herman, R., M'Rabet, N., Calvo-Esposito, R., Charlier, P., & Kerff, F. (2020). Structures of the free and inhibitors-bound forms of bromelain and ananain from Ananas comosus stem and in vitro study of their cytotoxicity. Scientific Reports. doi:10.1038/s41598-020-76172-5
Peer Reviewed verified by ORBi

Bourgot, I., Louis, T., Kasabova, M., Blacher, S., Reinheckel, T., Noël, A., & Maquoi, E. (20 September 2019). Impact of cancer associated fibroblasts-derived cathepsin B on breast cancer progression [Poster presentation]. Mechanobiology of Cancer Summer School 2019, La Cerdanya, Spain.

Bourgot, I., Louis, T., Kasabova, M., Blacher, S., Reinheckel, T., Noël, A., & Maquoi, E. (19 September 2019). Impact of cancer associated fibroblasts-derived cathepsin B on breast cancer progression [Paper presentation]. Mechanobiology of Cancer Summer School 2019, La Cerdanya, Spain.

Primac, I., Maquoi, E., Blacher, S., Heljasvaara, R., Van Deun, J., Smeland, H. Y. H., Canale, A., Louis, T., Stuhr, L., Sounni, N. E., Cataldo, D., Pihlajaniemi, T., Pequeux, C., De Wever, O., Gullberg, D., & Noël, A. (09 July 2019). Stromal integrin alpha11 regulates PDGFR-beta signaling and promotes breast cancer progression. Journal of Clinical Investigation, 130. doi:10.1172/JCI125890
Peer Reviewed verified by ORBi

Jansen, O., Desdemoustier, P., Maquoi, E., Marotte, A., DJIERRO, K., & Hamann, C. (17 May 2019). Screening of 25 Euphorbiaceae for their in vitro cytotoxic activity against two cancer cell lines [Poster presentation]. Phytoday 2019, BRUXELLES, Belgium.
Editorial reviewed

Saby, C., Collin, G., Sinane, M., Buache, E., Van Gulick, L., Saltel, F., Maquoi, E.* , & Morjani, H.*. (2019). DDR1 and MT1-MMP Expression Levels Are Determinant for Triggering BIK-Mediated Apoptosis by 3D Type I Collagen Matrix in Invasive Basal-Like Breast Carcinoma Cells. Frontiers in Pharmacology, 10, 462. doi:10.3389/fphar.2019.00462
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Louis, T., Bourgot, I., Primac, I., Maquoi, E., Blacher, S., & Noël, A. (2019). Novel 3D microscopy techniques and image analysis algorithms to study cancer-related in vitro spheroid models [Poster presentation]. Focus on Microscopy 2019, Londres, United Kingdom.

FOIDART, P., Yip, C., Radermacher, J., Blacher, S., Lienard, M., MONTERORUIZ, L., Maquoi, E., Montaudon, E., Chateau-Joubert, S., COLLIGNON, J., Coibion, M., Jossa, V., Marangoni, E., Noël, A., Sounni, N. E.* , & JERUSALEM, G.*. (2019). Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy. Clinical Cancer Research. doi:10.1158/1078-0432.CCR-18-1880
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Saby, C., Rammal, H., Magnien, K., Buache, E., Brassart-Pasco, S., Van-Gulick, L., Jeannesson, P., Maquoi, E.* , & Morjani, H.*. (2018). Age-related modifications of type I collagen impair DDR1-induced apoptosis in non-invasive breast carcinoma cells. Cell Adhesion and Migration. doi:10.1080/19336918.2018.1472182
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Louis, T., Blacher, S., Bourgot, I., Durré, T., Primac, I., Gillot, L., Maquoi, E., & Noël, A. (2018). Novel 3D microscopy techniques and image processing and quantification algorithms to study cancer-related biological models [Poster presentation]. Joint Meeting GIGA-Cancer Day 2018 / EDT-Cancerology, Liège, Belgium.

Saby, C., Rammal, H., Magnien, K., Pasco-Brassart, S., Maquoi, E., Jeannesson, P., & Morjani, H. (October 2016). Regulation of breast carcinoma cell proliferation and apoptosis by type I collagen aging and 3D confinement involves differential activation of DDR1 [Poster presentation]. EACR - GOODBYE FLAT BIOLOGY: MODELS, MECHANISMS AND MICROENVIRONMENT, Berlin, Germany.

Assent, D., Bourgot, I., Hennuy, B., Geurts, P., Foidart, J.-M., Noël, A., & Maquoi, E. (October 2016). A membrane-type- matrix metalloproteinase (MT1-MMP) - discoidin domain receptor 1 axis regulates collagen-induced apoptosis in breast cancer cells [Poster presentation]. EACR Meeting - Goodbye flat biology : models, mechanisms and microenvironment, Berlin, Germany.

Assent, D., Bourgot, I., Hennuy, B., Geurts, P., Noël, A., Foidart, J.-M., & Maquoi, E. (04 March 2016). A Membrane-Type-1 Matrix Metalloproteinase (MT1-MMP)- Discoïdin Domain Receptor 1 axis regulates collagen-induced apoptosis in breast cancer cells [Poster presentation]. International Joint Meeting of the German and French Societies for Matrix Biology, Freiburg, Germany.

Assent, D., Bourgot, I., Hennuy, B., Geurts, P., Noël, A., Foidart, J.-M., & Maquoi, E. (2015). A Membrane-Type-1 Matrix Metalloproteinase (MT1-MMP) - Discoidin Domain Receptor 1 Axis Regulates Collagen-Induced Apoptosis in Breast Cancer Cells. PLoS ONE, 10 (3), 0116006. doi:10.1371/journal.pone.0116006
Peer Reviewed verified by ORBi

Paye, A., Truong, A., Yip, C., Cimino, J., Blacher, S., Munaut, C., Cataldo, D., Foidart, J.-M., Maquoi, E., COLLIGNON, J., Delvenne, P., Jerusalem, G., Noël, A.* , & Sounni, N. E.*. (October 2014). EGFR activation and signaling in cancer cells are enhanced by the membrane-bound metalloprotease MT4-MMP. Cancer Research, 74 (23), 6758-70. doi:10.1158/0008-5472.CAN-13-2994
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Matheus, N., Hansen, S., Rozet, E., Peixoto, P., Maquoi, E., LAMBERT, V., Noël, A., Frederich, M., Mottet, D., & De Tullio, P. (January 2014). An Easy, Convenient Cell and Tissue Extraction Protocol for Nuclear Magnetic Resonance Metabolomics. Phytochemical Analysis, 25, 342-349. doi:10.1002/pca.2498
Peer Reviewed verified by ORBi

Maquoi, E., Assent, D., Foidart, J.-M., & Noël, A. (27 September 2013). Molecular mechanisms of type I collagen-induced apoptosis in breast carcinoma cells [Poster presentation]. 21st ECDO Euroconference on Apoptosis : Cell death, a biomedical paradigm, Paris, France.

Maquoi, E., Assent, D., Detilleux, J., Pequeux, C., Foidart, J.-M., & Noël, A. (26 January 2012). MT1-MMP protects breast carcinoma cells against type I collagen-induced apoptosis. Oncogene, 31 (4), 480-93. doi:10.1038/onc.2011.249
Peer Reviewed verified by ORBi

Noël, A., Gutierrez-Fernandez, A., Sounni, N. E., Behrendt, N., Maquoi, E., Lund, I., Cal, S., Hoyer-Hansen, G., & Lopez-Otin, C. (2012). New and Paradoxical Roles of Matrix Metalloproteinases in the Tumor Microenvironment. Frontiers in Pharmacology, 3 (140), 1. doi:10.3389/fphar.2012.00140
Peer Reviewed verified by ORBi

Van Steenkiste, M., Oltenfreiter, R., Frankenne, F., Vervoort, L., Maquoi, E., Noël, A., Foidart, J.-M., Van De Wiele, C., & De Vos, F. (2010). Membrane type 1 matrix metalloproteinase detection in tumors, using the iodinated endogenous [123I]-tissue inhibitor 2 of metalloproteinases as imaging agent. Cancer Biotherapy and Radiopharmaceuticals, 25 (5), 511-20. doi:10.1089/cbr.2010.0789
Peer Reviewed verified by ORBi

LORQUET, S., Berndt, S., Blacher, S., Gengoux, E., Peulen, O., Maquoi, E., Noël, A., Foidart, J.-M., Munaut, C., & Pequeux, C. (2010). Soluble forms of VEGF receptor-1 and -2 promote vascular maturation via mural cell recruitment. FASEB Journal, 24 (10), 3782-95. doi:10.1096/fj.09-149070
Peer Reviewed verified by ORBi

Noël, A., Jost, M., & Maquoi, E. (2008). Matrix metalloproteinases at cancer tumor-host interface. Seminars in Cell and Developmental Biology, 19, 52-60. doi:10.1016/j.semcdb.2007.05.011
Peer Reviewed verified by ORBi

Klein, J., Permana, P. A., Owecki, M., Chaldakov, G. N., Böhm, M., Hausman, G., Lapière, C. M., Atanassova, P., Sowiński, J., Fasshauer, M., Hausman, D. B., Maquoi, E., Tonchev, A. B., Peneva, V. N., Vlachanov, K. P., Fiore, M., Aloe, L., Slominski, A., Reardon, C. L., ... Pond, C. M. (January 2007). What are subcutaneous adipocytes really good for...? Experimental Dermatology, 16 (1), 45-70. doi:10.1111/j.1600-0625.2006.00519_1.x
Peer Reviewed verified by ORBi

Chabottaux, V., Sounni, N. E., Pennington, C. J., English, W. R., van den Brule, F., Blacher, S., Gilles, C., Munaut, C., Maquoi, E., Lopez-Otin, C., Murphy, G., Edwards, D. R., Foidart, J.-M., & Noël, A. (15 May 2006). Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases. Cancer Research, 66 (10), 5165-5172. doi:10.1158/0008-5472.CAN-05-3012
Peer Reviewed verified by ORBi

Vörös, G., Maquoi, E., Demeulemeester, D., Clerx, N., Collen, D., & Lijnen, R. (October 2005). Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology, 146 (10), 4545-4554. doi:10.1210/en.2005-0532
Peer Reviewed verified by ORBi

Maquoi, E., Vörös, G., Carmeliet, P., Collen, D., & Lijnen, R. (May 2005). Role of Gas-6 in adipogenesis and nutritionally induced adipose tissue development in mice. Arteriosclerosis, Thrombosis and Vascular Biology, 25 (5), 1002-1007. doi:10.1161/01.ATV.0000160611.68791.c6
Peer Reviewed verified by ORBi

Maquoi, E., Sounni, N. E., Devy, L., Olivier, F., Frankenne, F., Krell, H. W., Grams, F., Foidart, J.-M., & Noël, A. (15 June 2004). Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor. Clinical Cancer Research, 10 (12, Pt 1), 4038-4047. doi:10.1158/1078-0432.CCR-04-0125
Peer Reviewed verified by ORBi

Noël, A., Maillard, C., Rocks, N., Jost, M., Chabottaux, V., Sounni, N. E., Maquoi, E., Cataldo, D., & Foidart, J.-M. (June 2004). Membrane associated proteases and their inhibitors in tumour angiogenesis. Journal of Clinical Pathology, 57 (6), 577-584. doi:10.1136/jcp.2003.014472
Peer Reviewed verified by ORBi

Sounni, N. E., Roghi, C., Chabottaux, V., Janssen, M., Munaut, C., Maquoi, E., Galvez, B. G., Gilles, C., Frankenne, F., Murphy, G., Foidart, J.-M., & Noël, A. (02 April 2004). Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases. Journal of Biological Chemistry, 279 (14), 13564-13574. doi:10.1074/jbc.M307688200
Peer Reviewed verified by ORBi

Vörös, G., Maquoi, E., Collen, D., & Lijnen, R. (March 2004). Influence of membrane-bound tumor necrosis factor (TNF)-alpha on obesity and glucose metabolism. Journal of Thrombosis and Haemostasis, 2 (3), 507-513. doi:10.1111/j.1538-7933.2004.00612.x
Peer Reviewed verified by ORBi

Maquoi, E., Peyrollier, K., Noël, A., Foidart, J.-M., & Frankenne, F. (01 July 2003). Regulation of membrane-type 1 matrix metalloproteinase activity by vacuolar H+-ATPases. Biochemical Journal, 373 (Pt 1), 19-24. doi:10.1042/BJ20030170
Peer Reviewed verified by ORBi

Maquoi, E., Demeulemeester, D., Vörös, G., Collen, D., & Lijnen, R. (April 2003). Enhanced nutritionally induced adipose tissue development in mice with stromelysin-1 gene inactivation. Thrombosis and Haemostasis, 89 (4), 696-704. doi:10.1055/s-0037-1613586
Peer Reviewed verified by ORBi

Lijnen, R., Demeulemeester, D., Van Hoef, B., Collen, D., & Maquoi, E. (February 2003). Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice. Thrombosis and Haemostasis, 89 (2), 249-255. doi:10.1055/s-0037-1613439
Peer Reviewed verified by ORBi

Vörös, G., Maquoi, E., Collen, D., & Lijnen. (03 January 2003). Differential expression of plasminogen activator inhibitor-1, tumor necrosis factor-alpha, TNF-alpha converting enzyme and ADAMTS family members in murine fat territories. Biochimica et Biophysica Acta-Gene Structure and Expression, 1625 (1), 36-42. doi:10.1016/S0167-4781(02)00589-4
Peer Reviewed verified by ORBi

Lijnen, R., Maquoi, E., Morange, P., Vörös, G., Van Hoef, B., Kopp, F., Collen, D., Juhan-Vague, I., & Alessi, M.-C. (01 January 2003). Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1. Arteriosclerosis, Thrombosis and Vascular Biology, 23 (1), 78-84. doi:10.1161/01.ATV.0000044457.60665.DD
Peer Reviewed verified by ORBi

Lijnen, R., Maquoi, E., Demeulemeester, D., Van Hoef, B., & Collen, D. (August 2002). Modulation of fibrinolytic and gelatinolytic activity during adipose tissue development in a mouse model of nutritionally induced obesity. Thrombosis and Haemostasis, 88 (2), 345-353. doi:10.1055/s-0037-1613208
Peer Reviewed verified by ORBi

Maquoi, E., Munaut, C., Colige, A., Collen, D., & Lijnen, R. (April 2002). Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes, 51 (4), 1093-1101. doi:10.2337/diabetes.51.4.1093
Peer Reviewed verified by ORBi

Lijnen, R., Maquoi, E., Hansen, L. B., Van Hoef, B., Frederix, L., & Collen, D. (01 March 2002). Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arteriosclerosis, Thrombosis and Vascular Biology, 22 (3), 374-379. doi:10.1161/hq0302.104522
Peer Reviewed verified by ORBi

Sounni, N. E., Baramova, E., Munaut, C., Maquoi, E., Frankenne, F., Foidart, J.-M., & Noël, A. (01 March 2002). Expression of membrane type 1 matrix metalloproteinase (MT1-MMP) in A2058 melanoma cells is associated with MMP-2 activation and increased tumor growth and vascularization. International Journal of Cancer, 98 (1), 23-28. doi:10.1002/ijc.10134
Peer Reviewed verified by ORBi

Maquoi, E., Munaut, C., Colige, A., Lambert, C., Frankenne, F., Noël, A., Grams, F., Krell, H.-W., & Foidart, J.-M. (2002). Stimulation of matrix metalloproteinase-9 expression in human fibrosarcoma cells by synthetic matrix metalloproteinase inhibitors. Experimental Cell Research, 275 (1), 110-21. doi:10.1006/excr.2002.5489
Peer Reviewed verified by ORBi

Lijnen, R., Maquoi, E., Holvoet, P., Mertens, A., Lupu, F., Morange, P., Alessi, M. C., & Juhan-Vague, I. (June 2001). Adipose tissue expression of gelatinases in mouse models of obesity. Thrombosis and Haemostasis, 85 (6), 1111-1116. doi:10.1055/s-0037-1615971
Peer Reviewed verified by ORBi

Noël, A., Albert, V., Bajou, K., Bisson, C., Devy, L., Frankenne, F., Maquoi, E., Masson, V., Sounni, N. E., & Foidart, J.-M. (April 2001). New Functions of Stromal Proteases and Their Inhibitors in Tumor Progression. Surgical Oncology Clinics of North America, 10 (2), 417-32. doi:10.1016/s1055-3207(18)30073-5
Peer Reviewed verified by ORBi

GOFFIN, F., Maquoi, E., & Foidart, J.-M. (2001). Placentation et métalloprotéases. In Implantation et placentation. Physiologie, pathologies et traitements. Paris, France: MAsson.

Maquoi, E., Frankenne, F., Noël, A., Krell, H. W., Grams, F., & Foidart, J.-M. (15 December 2000). Type Iv Collagen Induces Matrix Metalloproteinase 2 Activation in Ht1080 Fibrosarcoma Cells. Experimental Cell Research, 261 (2), 348-59. doi:10.1006/excr.2000.5063
Peer Reviewed verified by ORBi

Maquoi, E., Frankenne, F., Baramova, E., Munaut, C., Sounni, N. E., Remacle, A., Noël, A., Murphy, G., & Foidart, J.-M. (14 April 2000). Membrane Type 1 Matrix Metalloproteinase-Associated Degradation of Tissue Inhibitor of Metalloproteinase 2 in Human Tumor Cell Lines. Journal of Biological Chemistry, 275 (15), 11368-78. doi:10.1074/jbc.275.15.11368
Peer Reviewed verified by ORBi

Maquoi, E., Munaut, C., Colige, A., Lambert, C., Frankenne, F., Noël, A., Grams, F., Krell, H. W., & Foidart, J.-M. (30 June 1999). Paradoxical Stimulation of Matrix Metalloproteinase-9 Expression in Ht1080 Cells by a Broad-Spectrum Hydroxamate-Based Matrix Metalloproteinase Inhibitor. Annals of the New York Academy of Sciences, 878, 744-6. doi:10.1111/j.1749-6632.1999.tb07779.x
Peer Reviewed verified by ORBi

Noël, A., Kebers, F., Maquoi, E., & Foidart, J.-M. (1999). Cell-Cell and Cell-Matrix Interactions During Breast Cancer Progression. Current Topics in Pathology. Ergebnisse der Pathologie, 183-193. doi:10.1007/978-3-642-58456-5_19
Peer Reviewed verified by ORBi

Noël, A., Hajitou, A., L'Hoir, C., Maquoi, E., Baramova, E., Lewalle, J.-M., Remacle, A., Kebers, F., Brown, P., Calberg-Bacq, C.-M., & Foidart, J.-M. (13 April 1998). Inhibition of Stromal Matrix Metalloproteases: Effects on Breast-Tumor Promotion by Fibroblasts. International Journal of Cancer, 76 (2), 267-73. doi:10.1002/(SICI)1097-0215(19980413)76:2<267::AID-IJC15>3.0.CO;2-9
Peer Reviewed verified by ORBi

Maquoi, E., Noël, A., Frankenne, F., Angliker, H., Murphy, G., & Foidart, J.-M. (13 March 1998). Inhibition of Matrix Metalloproteinase 2 Maturation and Ht1080 Invasiveness by a Synthetic Furin Inhibitor. FEBS Letters, 424 (3), 262-6. doi:10.1016/S0014-5793(98)00187-2
Peer Reviewed verified by ORBi

Maquoi, E., Polette, M., Nawrocki, B., Bischof, P., Noël, A., Pintiaux, A., Santavicca, M., Schaaps, J.-P., Pijnenborg, R., Birembaut, P., & Foidart, J.-M. (May 1997). Expression of Stromelysin-3 in the Human Placenta and Placental Bed. Placenta, 18 (4), 277-85. doi:10.1016/S0143-4004(97)80062-8
Peer Reviewed verified by ORBi

Maquoi, E., van den Brule, F. A., Castronovo, V., & Foidart, J.-M. (1997). Changes in the Distribution Pattern of Galectin-1 and Galectin-3 in Human Placenta Correlates with the Differentiation Pathways of Trophoblasts. Placenta, 18 (5-6, Jul-Aug), 433-9. doi:10.1016/S0143-4004(97)80044-6
Peer Reviewed verified by ORBi

Maquoi, E., Noël, A., & Foidart, J.-M. (1997). Matrix metalloproteinases in choriocarcinoma cell lines: a potential regulatory role of extracellular matrix components. In J.-M. Foidart, J. Aplin, P. Kaufmann, ... J.-P. Schaaps, Placenta. Trophoblast Research. Early Pregnancy (pp. 18, Supplement 2, Pages 123-142). Elsevier.

Maquoi, E., Schaaps, J.-P., Jacobs, J. L., Noël, A., & Foidart, J.-M. (1997). La prééclampsie est la conséquence d'un déficit de placentation: de la biologie aux considérations cliniques. Revue Médicale de Liège, 52 (7), 478-84.
Peer reviewed

Noël, A., Gilles, C., Bajou, K., Devy, L., Kebers, F., Lewalle, J. M., Maquoi, E., Munaut, C., Remacle, A., & Foidart, J.-M. (1997). Emerging Roles for Proteinases in Cancer. Invasion and Metastasis, 17 (5), 221-39.
Peer Reviewed verified by ORBi

Nawrocki, B., Polette, M. E., Marchand, V., Maquoi, E., Beorchia, A., Tournier, J. M., Foidart, J.-M., & Birembaut, P. (1996). Membrane-type matrix metalloproteinase-1 expression at the site of human placentation. Placenta, 17 (8), 565-72. doi:10.1016/S0143-4004(96)80073-7
Peer Reviewed verified by ORBi

Crescimanno, C., Foidart, J.-M., Noël, A., Polette, M., Maquoi, E., Birembaut, P., Baramova, E. N., Kauffmann, P., & Castellucci, M. (1996). Cloning of choriocarcinoma cells shows that invasion correlates with expression and activation of gelatinase A. Experimental Cell Research, 227, 240-251. doi:10.1006/excr.1996.0273
Peer Reviewed verified by ORBi

Noël, A., Lefebvre, O., Maquoi, E., Vanhoorde, L., Chenard, M. P., Mareel, M., Foidart, J.-M., Basset, P., & Rio, M. C. (1996). Stromelysin-3 expression promotes tumor take in nude mice. Journal of Clinical Investigation, 97, 1924-1930. doi:10.1172/JCI118624
Peer Reviewed verified by ORBi

Polette, M., Nawrocki, B., PINTIAUX, A., Massenat, C., Maquoi, E., Volders, L., SCHAAPS, J.-P., Birembaut, P., & Foidart, J.-M. (December 1994). Expression of gelatinases A and B and their tissue inhibitors by cells of early and term human placenta and gestational endometrium. Laboratory Investigation, 71 (6), 838-846.
Peer Reviewed verified by ORBi

Contact ORBi